Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | EGFR | P00533 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 3/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | IDO1 | P14902 | 3/20 | 0.41 |
| ▸ | TTR | P02766 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | XBP1 | P17861 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.36 |
| ▸ | ERCC1 | P07992 | 1/20 | 0.36 |
| ▸ | ERCC4 | Q92889 | 1/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.36 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7164454 | 0.85 | CYP4F2 (0.40) | EGFRNPC1RAB9ASMN1; SMN2HPGD | |
| SCHEMBL30442346 | 0.85 | CYP4F2 (0.40) | EGFRNPC1RAB9ASMN1; SMN2HPGD | |
| SCHEMBL17013472 | 0.85 | CSNK2A1 (0.52) | CYP3A4PNMTTAAR1 | |
| SCHEMBL8772771 | 0.85 | TRPA1 (0.43) | SMN1; SMN2IDO1TSHRCYP1A2MAPK1 | |
| SCHEMBL12900227 | 0.85 | RECQL (0.39) | RECQLEGFRNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL30989341 | 0.85 | RECQL (0.39) | RECQLEGFRNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL15778552 | 0.85 | LMNA (0.43) | RECQLEGFRNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL16958596 | 0.81 | ALOX5 (0.40) | RECQLNPC1RAB9ASMN1; SMN2HPGD | |
| SCHEMBL31621229 | 0.81 | RECQL (0.43) | RECQLEGFRNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL92905 | 0.80 | IDO1 (0.58) | RECQLSMN1; SMN2IDO1HSD17B10TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11827612-B2 | Hydroxamic acid derivative, method for producing same and use thereof | INSTITUTE OF MEDICINAL BIOTECHNOLOGY, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2023-11-28 | — | — | US | disclosed |
| US-11827612-B2 | Hydroxamic acid derivative, method for producing same and use thereof | INSTITUTE OF MEDICINAL BIOTECHNOLOGY, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2023-11-28 | — | — | US | disclosed |
| US-20220033369-A1 | HYDROXAMIC ACID DERIVATIVE, METHOD FOR PRODUCING SAME AND USE THEREOF | INSTITUTE OF MEDICINAL BIOTECHNOLOGY, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2022-02-03 | — | — | US | disclosed |
| WO-2021052353-A1 | HYDROXAMIC ACID DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 中国医学科学院医药生物技术研究所 | 2021-03-25 | — | — | WO | disclosed |
| US-8980904-B2 | Heterocyclic substituted pyrimidine compound | Xuanzhu Pharma Co., Ltd. (CN) | 2015-03-17 | — | — | US | disclosed |
| US-20140288063-A1 | Heterocyclic Substituted Pyrimidine Compound | Xuanzhu Pharma Co., Ltd. (CN) | 2014-09-25 | — | — | US | disclosed |
| EP-2415741-A1 | METHOD FOR PRODUCING ALCOHOL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2012-02-08 | — | — | EP | disclosed |
| EP-2415742-A1 | METHOD FOR PRODUCING ALCOHOL COMPOUND AND CATALYST THEREFOR | Sumitomo Chemical Company, Limited (JP) | 2012-02-08 | — | — | EP | disclosed |
| US-20120029195-A1 | METHOD FOR PRODUCING ALCOHOL COMPOUND AND CATALYST THEREFOR | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-02-02 | — | — | US | disclosed |
| US-20120010417-A1 | METHOD FOR PRODUCING ALCOHOL COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-01-12 | — | — | US | disclosed |
| EP-2033944-A1 | PROCESS FOR PRODUCTION OF HALOGEN-SUBSTITUTED BENZENEDIMETHANOL | Sumitomo Chemical Company, Limited (JP) | 2009-03-11 | — | — | EP | disclosed |
| EP-1978008-A1 | METHOD FOR PRODUCING HALOGEN-SUBSTITUTED BENZENEDIMETHANOL | Sumitomo Chemical Company, Limited (JP) | 2008-10-08 | — | — | EP | disclosed |
| US-20080070154-A1 | DECOMPOSABLE RESIN COMPOSITION AND PATTERN-FORMING MATERIAL INCLUDING THE SAME | FUJIFILM CORPORATION (JP) | 2008-03-20 | — | — | US | disclosed |
| US-20080070154-A1 | DECOMPOSABLE RESIN COMPOSITION AND PATTERN-FORMING MATERIAL INCLUDING THE SAME | FUJIFILM CORPORATION (JP) | 2008-03-20 | — | — | US | disclosed |
| EP-1894953-A2 | Decomposable resin composition and pattern-forming material including the same | FUJIFILM Corporation (JP) | 2008-03-05 | — | — | EP | disclosed |
| US-20070213570-A1 | reacting a halogen-substituted terephthalic acid diester with a borohydride compound in the presence of an alcohol and a solvent | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-09-13 | — | — | US | disclosed |
| EP-1783108-A1 | METHOD FOR PRODUCING HALOGEN-SUBSTITUTED BENZENEDIMETHANOL | Sumitomo Chemical Company, Limited (JP) | 2007-05-09 | — | — | EP | disclosed |
| US-5310858-A | Process for preparing polymers of p-xylylene from p-xylylene diesters | HOECHST AKTIENGESELLSCHAFT (DE) | 1994-05-10 | — | — | US | disclosed |
| EP-0554675-A1 | Process for the preparation of para-xylylene polymers and derivatives thereof | HOECHST AKTIENGESELLSCHAFT (DE) | 1993-08-11 | — | — | EP | disclosed |
| US-4031163-A | CROSS LINKING SELF-EXTINGUISHING, THERMAL STABILITY | DYNAMIT NOBEL AKTIENGESELLSCHAFT (DT) | 1977-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120010417-A1 | METHOD FOR PRODUCING ALCOHOL COMPOUND | ADH1A, ADH1C, ADH5 | RECQL 4728/4885EGFR 2808/4885NPC1 2661/4885 |
| US-20070213570-A1 | reacting a halogen-substituted terephthalic acid diester with a borohydride compound in the presence of an alcohol and a solvent | ADH1A, ADH1C, CYP4A11 | RECQL 2285/4885EGFR 1289/4885NPC1 2782/4885 |
| US-20140288063-A1 | Heterocyclic Substituted Pyrimidine Compound | PDE3B, PDE5A, PDE3A | RECQL 320/4885EGFR 3450/4885NPC1 3718/4885 |
| US-20220033369-A1 | HYDROXAMIC ACID DERIVATIVE, METHOD FOR PRODUCING SAME AND USE THEREOF | HACL2, NAAA, LCT | RECQL 3451/4885EGFR 3685/4885NPC1 2740/4885 |
| US-20120029195-A1 | METHOD FOR PRODUCING ALCOHOL COMPOUND AND CATALYST THEREFOR | ADH1A, ADH1C, ADH5 | RECQL 4464/4885EGFR 3137/4885NPC1 3195/4885 |
| US-11827612-B2 | Hydroxamic acid derivative, method for producing same and use thereof | HACL2, NAAA, LCT | RECQL 3451/4885EGFR 3685/4885NPC1 2740/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.